FDA Inspection 958542 — Center For Advanced Reproductive Medicine & Fertility

Center For Advanced Reproductive Medicine & Fertility — FEI 3003945126

The FDA completed an inspection of Center For Advanced Reproductive Medicine & Fertility on Feb 11, 2016 in Edison, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 11, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Edison, NJ (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1223021 CFR 1271.50(a)Responsible person to determine, document
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
1228221 CFR 1271.75(d)Donors with risks not determined ineligible
1228621 CFR 1271.80(b)Specimen collections not timely
1249321 CFR 1271.90(c)Eligibility not required--warning labels

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.